Porous Fe 2 O 3 nanorods were obtained using a facile chemical solution method with subsequent calcination. The structures and morphological evolution were characterized by X-ray diffraction, field emission scanning electron microscopy, thermogravimetric-differential thermal analysis, and Brunauer-Emmett-Teller (BET) N 2 adsorption-desorption analyses. The calculated BET surface area of the porous Fe 2 O 3 nanorods was 18.8 m²·g -1 . The porous Fe 2 O 3 nanorods were used as a catalyst to photodegrade Rhodamine B, methylene blue, methyl orange, p-nitrophenol, and eosin B. Compared to the commercial Fe 2 O 3 powder, the as-prepared porous Fe 2 O 3 nanorods exhibited higher catalytic activities owing to their large surface areas and porous nanostructures. The photocatalytic reaction rate constant of the porous Fe 2 O 3 nanorods in the photocatalytic decomposition of Rhodamine B under simulated solar light was calculated to be 0.0131 min -1 .Moreover, the catalyst was found to have superior stability and reusability.
Background: Diffuse large B-cell lymphoma used to be defined as germinal center B-like and non-germinal center B-like subtypes, associated with different prognoses, but the conventional classification does not meet the needs of clinical practice because of diffuse large B-cell lymphoma heterogeneity, a problem that might be improved by selection of miRNAs as biomarkers. Methods: Twelve patients with diffuse large B-cell lymphomas were used to screen out the aberrant miRNA profile using miRNA microarray technology in 2 patient subtypes (6 germinal center B-like and 6 non-germinal center B-like patients). The potential biomarkers were further analyzed using the quantitative reverse transcription-polymerase chain reaction method in 95 diffuse large B-cell lymphoma patients to investigate relationships between expression levels of potent miRNA, clinicopathological features, and survival rates of patients. Results: miR-208a-5p, miR-296-5p and miR-1304-5p were screened as potential biomarkers. miR-208a-5p and miR-296-5p were shown to be associated with better survival of patients after Kaplan-Meier analysis, whereas miR-1304-5p overexpression indicated a poor survival prognosis independent of the diffuse large B-cell lymphoma subtype. In addition, changes of miR-296-5p and miR-1304-5p expression, the International Prognostic Index status and the age of patients were all independent indicators for diffuse large B-cell lymphoma prognosis. We also found that high miR-208a-5p expression led to better outcomes in diffuse large B-cell lymphoma patients with similar International Prognostic Index scores; however high miR-1304-5p expression tended to indicate the opposite. Conclusions: MiR-208a-5p, miR-296-5p and miR-1304-5p levels might be potential biomarkers for the prediction of the prognosis of diffuse large B-cell lymphoma patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.